LEE M ELLIS to Disease-Free Survival
This is a "connection" page, showing publications LEE M ELLIS has written about Disease-Free Survival.
Connection Strength
0.198
-
Bevacizumab beyond progression: does this make sense? J Clin Oncol. 2008 Nov 20; 26(33):5313-5.
Score: 0.035
-
Can inhibition of angiogenic pathways increase the efficacy of intravenous 5-fluorouracil-based regimens? Clin Colorectal Cancer. 2004 Oct; 4 Suppl 2:S69-73.
Score: 0.027
-
Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer. Clin Colorectal Cancer. 2021 03; 20(1):e53-e60.
Score: 0.020
-
Antiangiogenic therapy in oncology: current status and future directions. Lancet. 2016 Jul 30; 388(10043):518-29.
Score: 0.015
-
Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis. Clin Cancer Res. 2014 Feb 15; 20(4):837-46.
Score: 0.013
-
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer. PLoS One. 2013; 8(10):e77117.
Score: 0.013
-
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer. 2013 Dec 15; 119(24):4231-41.
Score: 0.012
-
Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res. 2012 Jul 15; 18(14):3982-91.
Score: 0.011
-
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. J Clin Oncol. 2009 Nov 20; 27(33):5660-9.
Score: 0.010
-
Clinical and in vitro studies of imatinib in advanced carcinoid tumors. Clin Cancer Res. 2007 Jan 01; 13(1):234-40.
Score: 0.008
-
Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg. 2006 Jun; 141(6):537-43; discussion 543-4.
Score: 0.008
-
Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg. 2006 Feb; 10(2):240-8.
Score: 0.007
-
Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol. 2005 Aug; 12(8):616-28.
Score: 0.007
-
Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol. 2004 Sep; 11(9):869-74.
Score: 0.007
-
Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg. 2004 Jan; 8(1):56-62; discussion 62-3.
Score: 0.006